Doxorubicin administration in rats led to systolic dysfunction in 67% of cases with a 30% decrease in left ventricular ejection fraction, alongside compensatory mechanisms like slowed relaxation.
Does doxorubicin administration alter pressure-volume loop characteristics in a rat model of cardiomyopathy?
Doxorubicin-induced cardiomyopathy in rats is characterized by specific compensatory mechanisms including slowed myocardial relaxation, reduced peripheral arterial resistance, and heart rate reduction to preserve LV filling.
The Aim of the study was a detailed investigation of pressure volume-loop (PV-loop) curves in the rat heart during development of doxorubicin cardiomyopathy. Materials and methods . Cardiomyopathy in rats has been developed after 4 weeks doxorubicin administration (2 mg / kg weekly). Results . Echocardiographic study of rats in 8 weeks from onset of doxorubicin administration showed preponderance of systolic dysfunction (67 %) with decrease of left ventricular (LV) ejection fraction (EF) by 30 %. Simultaneous registration of LV pressure and volume showed that diastolic LV volume was preserved in doxorubicin-treated rats due to considerable lengthening of the diastole, the heart rate was reduced by 22 %. These hearts also showed slowing of relaxation, reduced maximal rate of pressure development and stroke work, as well as significant reduction in peripheral arterial resistance. Diastolic dysfunction differed from the systolic one by normal systolic EF and preserved LV contractility index as well as lower diastolic LV pressure throughout the diastole. Conclusions . Based on these data, four compensatory mechanisms associated with cardiomyopathy were distinguished - 1) slowing of myocardial relaxation, prolonging myofibrillar active state, 2) reduction of peripheral arterial resistance for easier LV ejection, 3) heart rate reduction, prolonging diastolic pause and thus facilitating better LV filling and 4) increased pressure in the small circle, also contributing to the LV rapid filling.
Абрамов et al. (Thu,) conducted a other in Doxorubicin cardiomyopathy. Doxorubicin was evaluated on Pressure-volume loop characteristics (systolic and diastolic dysfunction). Doxorubicin administration in rats led to systolic dysfunction in 67% of cases with a 30% decrease in left ventricular ejection fraction, alongside compensatory mechanisms like slowed relaxation.